Work

Species-Specific Antimicrobial Resistance Among Bacterial Isolates from Blood Cultures in ICU and Non-ICU Settings at a Tertiary Hospital in Western Romania, 2024–2025

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Antimicrobial resistance among bloodstream pathogens compromises empirical treatment and infection prevention, but contemporary hospital-level data from western Romania remain limited. We characterized pathogen distribution and resistance, compared resistance by year and intensive care unit (ICU) location, and identified factors associated with meropenem resistance. Methods: This retrospective, single-center study included bacterial isolates recovered from blood cultures at a tertiary hospital in Timișoara, Romania, during 2024–2025. The first isolate of each species per patient and calendar year was retained. Quantitative susceptibility results were reinterpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) version 15.0. Species-specific, annual, and ICU/non-ICU comparisons and multivariable logistic regression were performed. Results: The cohort included 1055 isolates from 1017 patients. Klebsiella pneumoniae was most frequent (32.1%), followed by Escherichia coli (18.7%), Staphylococcus aureus (17.0%), and Acinetobacter baumannii (12.4%). K. pneumoniae resistance was 68.0% to meropenem, 75.1% to ceftazidime, and 73.7% to ciprofloxacin; A. baumannii resistance was 89.1% to meropenem and 91.5% to amikacin. After Benjamini–Hochberg correction, the only statistically significant annual difference was an increase in the proportion of A. baumannii isolates categorized as colistin-resistant by VITEK 2, from 6.0% to 41.9% (adjusted p < 0.001); this finding was not confirmed by reference broth microdilution. Conclusions: Resistance was high, particularly in K. pneumoniae and A. baumannii, with an ICU-associated gradient. ICU-focused surveillance and antimicrobial stewardship are warranted. The observed increase in A. baumannii colistin resistance requires confirmation by reference broth microdilution.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236193350
FWCI:
Cites:
Cited by:
Related to: 10